{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:22:08Z","timestamp":1790821328759,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T00:00:00Z","timestamp":1503360000000},"content-version":"vor","delay-in-days":386,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.jcin.2016.06.005","type":"journal-article","created":{"date-parts":[[2016,8,15]],"date-time":"2016-08-15T14:30:21Z","timestamp":1471271421000},"page":"1721-1728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Experience With the Absorb Everolimus-Eluting Bioresorbable Vascular\u00a0Scaffold in\u00a0Arteries Below the Knee"],"prefix":"10.1016","volume":"9","author":[{"given":"Ramon L.","family":"Varcoe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Schouten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon D.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew F.","family":"Lennox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2016.06.005_bib1","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jvs.2011.07.099","article-title":"Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease","volume":"55","author":"Bosiers","year":"2012","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jcin.2016.06.005_bib2","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1093\/eurheartj\/ehr144","article-title":"Sirolimus-eluting stents vs. bare-metal stents for\u00a0treatment of focal lesions in infrapopliteal arteries: a double-blind, multi-centre, randomized clinical trial","volume":"32","author":"Rastan","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2016.06.005_bib3","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1016\/j.jacc.2012.08.989","article-title":"A\u00a0prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial","volume":"60","author":"Scheinert","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2016.06.005_bib4","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/1526602815592206","article-title":"An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: a supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"22","author":"Jaff","year":"2015","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jcin.2016.06.005_bib5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2016.06.005_bib6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/CIRCULATIONAHA.113.001790","article-title":"Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans","volume":"129","author":"Otsuka","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2016.06.005_bib7","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1509038","article-title":"Everolimus-eluting bioresorbable scaffolds for coronary artery disease","volume":"373","author":"Ellis","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2016.06.005_bib8","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.jacc.2011.05.050","article-title":"Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes","volume":"58","author":"Serruys","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2016.06.005_bib9","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1177\/1526602815575256","article-title":"Initial experience with the absorb bioresorbable vascular scaffold below the knee: six-month clinical and imaging outcomes","volume":"22","author":"Varcoe","year":"2015","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jcin.2016.06.005_bib10","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00270-009-9765-6","article-title":"Angioplasty or primary stenting for infrapopliteal lesions: results of a prospective randomized trial","volume":"33","author":"Randon","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jcin.2016.06.005_bib11","first-page":"251","article-title":"Retrograde recanalization of an occluded posterior tibial artery by using a posterior tibial cutdown: two case reports","volume":"20","author":"Iyer","year":"1990","journal-title":"Catheter Cardiovasc Diag"},{"key":"10.1016\/j.jcin.2016.06.005_bib12","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jvs.2008.01.005","article-title":"Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia","volume":"47","author":"Romiti","year":"2008","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jcin.2016.06.005_bib13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1583\/09-2691.1","article-title":"Infragenicular stent implantation for below-the-knee atherosclerotic disease: clinical evidence from an international collaborative meta-analysis on 640 patients","volume":"16","author":"Biondi-Zoccai","year":"2009","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jcin.2016.06.005_bib14","first-page":"1042","article-title":"Major adverse limb events and wound healing following infrapopliteal artery stent implantation in patients with critical limb ischemia: the XCELL trial","volume":"80","author":"Rocha-Singh","year":"2012","journal-title":"Catheter Cardiovasc Interven"},{"key":"10.1016\/j.jcin.2016.06.005_bib15","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1148\/radiol.11101357","article-title":"Percutaneous transluminal angioplasty versus turbostatic carbon-coated stents in infrapopliteal arteries: InPeria II trial","volume":"261","author":"Rand","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.jcin.2016.06.005_bib16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1583\/1545-1550-20.2.131","article-title":"Meta-analysis of outcomes of endovascular treatment of infrapopliteal occlusive disease with drug-eluting stents","volume":"20","author":"Antoniou","year":"2013","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jcin.2016.06.005_bib17","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.jcin.2013.08.007","article-title":"Drug-eluting stents for revascularization of infrapopliteal arteries: updated meta-analysis of randomized trials","volume":"6","author":"Fusaro","year":"2013","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2016.06.005_bib18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.CIR.102.4.399","article-title":"Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans","volume":"102","author":"Tamai","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2016.06.005_bib19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jcin.2013.09.009","article-title":"Evaluation of the biodegradable peripheral Igaki-Tamai stent in the treatment of de novo lesions in the superficial femoral artery: the GAIA study","volume":"7","author":"Werner","year":"2014","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2016.06.005_bib20","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00270-008-9472-8","article-title":"AMS INSIGHT\u2014Absorbable Metal Stent Implantation for Treatment of Below-the-Knee Critical Limb Ischemia: 6-month analysis","volume":"32","author":"Bosiers","year":"2009","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jcin.2016.06.005_bib21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1540-8183.2004.04081.x","article-title":"Drug-eluting bioabsorbable magnesium stent","volume":"17","author":"Di Mario","year":"2004","journal-title":"J\u00a0Interv Cardiol"},{"key":"10.1016\/j.jcin.2016.06.005_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1583\/04-1349R.1","article-title":"Preliminary results after application of absorbable metal stents in patients with critical limb ischemia","volume":"12","author":"Peeters","year":"2005","journal-title":"J\u00a0Endovasc Ther"},{"issue":"Suppl F","key":"10.1016\/j.jcin.2016.06.005_bib23","doi-asserted-by":"crossref","first-page":"F94","DOI":"10.4244\/EIJV5IFA16","article-title":"Current state of the absorbable metallic (magnesium) stent","volume":"5","author":"Waksman","year":"2009","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2016.06.005_bib24","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0140-6736(08)60415-8","article-title":"A\u00a0bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial","volume":"371","author":"Ormiston","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2016.06.005_bib25","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.4244\/EIJV9I11A217","article-title":"Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months","volume":"9","author":"Serruys","year":"2014","journal-title":"EuroIntervention"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879816307464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879816307464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:03:46Z","timestamp":1761847426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879816307464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":25,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S1936879816307464"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2016.06.005","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experience With the Absorb Everolimus-Eluting Bioresorbable Vascular\u00a0Scaffold in\u00a0Arteries Below the Knee","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2016.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American College of Cardiology Foundation. Published by Elsevier","name":"copyright","label":"Copyright"}]}}